Literature DB >> 16455969

Hyperthermia enhances CTL cross-priming.

Hongzhen Shi1, Tinghua Cao, John E Connolly, Laurence Monnet, Lynda Bennett, Sylvie Chapel, Claude Bagnis, Patrice Mannoni, Jean Davoust, A Karolina Palucka, Jacques Banchereau.   

Abstract

Dendritic cells (DCs) loaded with killed allogeneic melanoma cells can cross-prime naive CD8(+) T cells to differentiate into melanoma-specific CTLs in 3-wk cultures. In this study we show that DCs loaded with killed melanoma cells that were heated to 42 degrees C before killing are more efficient in cross-priming of naive CD8(+) T cells than DCs loaded with unheated killed melanoma cells. The enhanced cross-priming was demonstrated by several parameters: 1) induction of naive CD8(+) T cell differentiation in 2-wk cultures, 2) enhanced killing of melanoma peptide-pulsed T2 cells, 3) enhanced killing of HLA-A*0201(+) melanoma cells in a standard 4-h chromium release assay, and 4) enhanced capacity to prevent tumor growth in vitro in a tumor regression assay. Two mechanisms might explain the hyperthermia-induced enhanced cross-priming. First, heat-treated melanoma cells expressed increased levels of 70-kDa heat shock protein (HSP70), and enhanced cross-priming could be reproduced by overexpression of HSP70 in melanoma cells transduced with HSP70 encoding lentiviral vector. Second, hyperthermia resulted in the increased transcription of several tumor Ag-associated Ags, including MAGE-B3, -B4, -A8, and -A10. Thus, heat treatment of tumor cells permits enhanced cross-priming, possibly via up-regulation of both HSPs and tumor Ag expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455969     DOI: 10.4049/jimmunol.176.4.2134

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Heat shock enhances the expression of cytotoxic granule proteins and augments the activities of tumor-associated antigen-specific cytotoxic T lymphocytes.

Authors:  Akari Takahashi; Toshihiko Torigoe; Yasuaki Tamura; Takayuki Kanaseki; Tomohide Tsukahara; Yasushi Sasaki; Hidekazu Kameshima; Tetsuhiro Tsuruma; Koichi Hirata; Takashi Tokino; Yoshihiko Hirohashi; Noriyuki Sato
Journal:  Cell Stress Chaperones       Date:  2012-07-11       Impact factor: 3.667

2.  Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells.

Authors:  Irena Adkins; Lenka Sadilkova; Nada Hradilova; Jakub Tomala; Marek Kovar; Radek Spisek
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

Review 3.  Fever and the thermal regulation of immunity: the immune system feels the heat.

Authors:  Sharon S Evans; Elizabeth A Repasky; Daniel T Fisher
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

Review 4.  Tumor cell lysates as immunogenic sources for cancer vaccine design.

Authors:  Fermín E González; Alejandra Gleisner; Felipe Falcón-Beas; Fabiola Osorio; Mercedes N López; Flavio Salazar-Onfray
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells.

Authors:  Davor Frleta; Chun I Yu; Eynav Klechevsky; Anne-Laure Flamar; Gerard Zurawski; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Peptidases released by necrotic cells control CD8+ T cell cross-priming.

Authors:  Jaba Gamrekelashvili; Tamar Kapanadze; Miaojun Han; Josef Wissing; Chi Ma; Lothar Jaensch; Michael P Manns; Todd Armstrong; Elizabeth Jaffee; Ayla O White; Deborah E Citrin; Firouzeh Korangy; Tim F Greten
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

Review 7.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06

Review 8.  Interactions of tumor cells with dendritic cells: balancing immunity and tolerance.

Authors:  M V Dhodapkar; K M Dhodapkar; A K Palucka
Journal:  Cell Death Differ       Date:  2007-10-19       Impact factor: 15.828

Review 9.  Dendritic cells: a critical player in cancer therapy?

Authors:  Anna Karolina Palucka; Hideki Ueno; Joseph Fay; Jacques Banchereau
Journal:  J Immunother       Date:  2008 Nov-Dec       Impact factor: 4.456

10.  Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy.

Authors:  Tomoaki Takada; Toshiharu Yamashita; Makito Sato; Akiko Sato; Ichiro Ono; Yasuaki Tamura; Noriyuki Sato; Atsushi Miyamoto; Akira Ito; Hiroyuki Honda; Kazumasa Wakamatsu; Shosuke Ito; Kowichi Jimbow
Journal:  J Biomed Biotechnol       Date:  2009-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.